SPRY ARS PHARMACEUTICALS INC
FollowCOM (common), issuer CIK 1671858
Filings received so far for Q3 2026: 5 13F filers report a position in SPRY shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Norman Fields, Gottscho Capital Managem… | 63,380 | $273K | 0.08% | -7,700 | 13F-HRTimeline |
| CX Institutional | 2,890 | $12K | <0.01% | -5,500 | 13F-HRTimeline |
| Versant Capital Management, Inc | 2,108 | $9.09K | <0.01% | +1,117 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 1,594 | $6.87K | <0.01% | +1,220 | 13F-HRTimeline |
| GAMMA Investing LLC | 808 | $3.48K | <0.01% | -448 | 13F-HRTimeline |